Abstract:Motivation: While drug combination therapies are a well-established concept in cancer treatment, identifying novel synergistic combinations is challenging due to the size of combinatorial space. However, computational approaches have emerged as a time- and cost-efficient way to prioritize combinations to test, based on recently available large-scale combination screening data. Recently, Deep Learning has had an impact in many research areas by achieving new state-of-the-art model performance. However, Deep Learning has not yet been applied to drug synergy prediction, which is the approach we present here, termed DeepSynergy. DeepSynergy uses chemical and genomic information as input information, a normalization strategy to account for input data heterogeneity, and conical layers to model drug synergies.Results: DeepSynergy was compared to other machine learning methods such as Gradient Boosting Machines, Random Forests, Support Vector Machines and Elastic Nets on the largest publicly available synergy dataset with respect to mean squared error. DeepSynergy significantly outperformed the other methods with an improvement of 7.2% over the second best method at the prediction of novel drug combinations within the space of explored drugs and cell lines. At this task, the mean Pearson correlation coefficient between the measured and the predicted values of DeepSynergy was 0.73. Applying DeepSynergy for classification of these novel drug combinations resulted in a high predictive performance of an AUC of 0.90. Furthermore, we found that all compared methods exhibit low predictive performance when extrapolating to unexplored drugs or cell lines, which we suggest is due to limitations in the size and diversity of the dataset. We envision that DeepSynergy could be a valuable tool for selecting novel synergistic drug combinations.Availability and implementation: DeepSynergy is available via www.bioinf.jku.at/software/DeepSynergy.Contact: klambauer@bioinf.jku.at.Supplementary information: Supplementary data are available at Bioinformatics online.

ChemicalX: A Deep Learning Library for Drug Pair Scoring

A Unified View of Relational Deep Learning for Drug Pair Scoring

DrugMetric: quantitative drug-likeness scoring based on chemical space distance

DrugEx: Deep Learning Models and Tools for Exploration of Drug-Like Chemical Space

OpenChem: A Deep Learning Toolkit for Computational Chemistry and Drug Design

A deep-learning view of chemical space designed to facilitate drug discovery

MatchMaker: A Deep Learning Framework for Drug Synergy Prediction

DeepSynergy: predicting anti-cancer drug synergy with Deep Learning

DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations

MDNNSyn: A Multi-Modal Deep Learning Framework for Drug Synergy Prediction

DeepDrug: A General Graph-Based Deep Learning Framework for Drug-Drug Interactions and Drug-Target Interactions Prediction

DFRscore: Deep Learning-Based Scoring of Synthetic Complexity with Drug-Focused Retrosynthetic Analysis for High-Throughput Virtual Screening

Distributed representations of graphs for drug pair scoring

DeepPurpose: a deep learning library for drug–target interaction prediction

Prediction of chemical compounds properties using a deep learning model

DrugSK: A Stacked Ensemble Learning Framework for Predicting Drug Combinations of Multiple Diseases

A Deep Neural Network for Predicting Synergistic Drug Combinations on Cancer

Deep graph contrastive learning model for drug-drug interaction prediction

Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning

CCSynergy: an integrative deep-learning framework enabling context-aware prediction of anti-cancer drug synergy

Efficient Exploration of Chemical Space with Docking and Deep Learning